Kalderos provides services and technology solutions that address some of the biggest challenges of the US healthcare system. We work with healthcare providers, drug manufacturers, payers, and government agencies alike, enabling everyone to focus on the core mission of healthcare -- improving the lives and health of people.
The only party financially harmed due to 340B duplicate discounts are drug manufacturers. HRSA and CMS continue to struggle to offer real solutions to protect manufacturers from paying duplicate discounts.
Kalderos' Transactional Data Exchange and Validation Application.
We are industry experts, user-centered designers, and data scientists. We apply the power of insight, design and analytics to develop powerful solutions that delight our users and transform the business of healthcare.
Founder & General Manager
Jeremy Docken is the founder and General Manager of Kalderos. His deep expertise in both 340B and Medicaid has given him a unique perspective on the issue of 340B duplicate discounts and how the problem may be solved in a manner that works for all stakeholders. Jeremy can frequently be found speaking at industry conferences or attending meetings with a wide variety of program stakeholders.
Founder & CIO
Jim is a founder and Chief Information Officer at Kalderos. Jim is an IT professional with extensive experience in developing and executing IT strategies that support overall business growth and productivity initiatives. At Kalderos, Jim works to align business and technical requirements for critical IT initiatives and creates smart and workable solutions to complex problems.
Steve Zielinski RPh
Director, Industry Relations
Steve is a Director of Industry Relations at Kalderos. With a combination of Pharmaceutical experience and industry knowledge, Steve’s focus is on ensuring industry stakeholders understand Kalderos’ strategic marketplace objectives and help to align their needs with Kalderos’ solutions.
Kalderos LLC © 2018 All rights reserved